| dc.contributor.advisor | Maher, Stephen | |
| dc.contributor.author | Picardo, Sarah Louise | |
| dc.date.accessioned | 2017-06-27T15:31:58Z | |
| dc.date.available | 2017-06-27T15:31:58Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Sarah Louise Picardo, 'The immunomodulatory chemokine CCL28 in oesophageal disease progression', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Surgery, 2014, pp 374 | |
| dc.identifier.other | THESIS 10734 | |
| dc.identifier.uri | http://hdl.handle.net/2262/80466 | |
| dc.description.abstract | Barrett’s oesophagus (BO) develops in response to bile acid reflux and confers increased risk of progression to oesophageal adenocarcinoma (OAC). During this disease progression, the immune microenvironment of the oesophageal tissue changes. Gene expression of the immunomodulatory chemokine CCL28 has previously been shown to be increased in OAC; in this work, its role in oesophageal disease progression is examined. | |
| dc.format | 1 volume | |
| dc.language.iso | en | |
| dc.publisher | Trinity College (Dublin, Ireland). School of Medicine. Discipline of Surgery | |
| dc.relation.isversionof | http://stella.catalogue.tcd.ie/iii/encore/record/C__Rb16195726 | |
| dc.subject | Surgery, Ph.D. | |
| dc.subject | Ph.D. Trinity College Dublin | |
| dc.title | The immunomodulatory chemokine CCL28 in oesophageal disease progression | |
| dc.type | thesis | |
| dc.type.supercollection | thesis_dissertations | |
| dc.type.supercollection | refereed_publications | |
| dc.type.qualificationlevel | Doctoral | |
| dc.type.qualificationname | Doctor of Philosophy (Ph.D.) | |
| dc.rights.ecaccessrights | openAccess | |
| dc.format.extentpagination | pp 374 | |
| dc.description.note | TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie | |
